Myeloid Derived Suppressor Cell Quantity prior to Treatment with Ipilimumab as a Biomarker of Overall Survival in Patients with Metastatic Melanoma / Ascierto, Paolo Antonio. - (2012).
Myeloid Derived Suppressor Cell Quantity prior to Treatment with Ipilimumab as a Biomarker of Overall Survival in Patients with Metastatic Melanoma
PAOLO ANTONIO ASCIERTO
2012
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.


